More recently, Tang et al. used iPSCs from a deaf patient with a HL-associated variant in the MYO7A gene and corrected the variant using CRISPR/Cas9 technology (Tang et al. 2016). The gene discussed is MYO7A; the disease is Hodgkins lymphoma.